| Patents for A61P - Specific therapeutic activity of chemical compounds or medicinal preparations (3,181) |
|---|
| 09/05/2000 | US6114365 Arylmethyl-carbonylamino-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 08/31/2000 | WO2000050400A1 2-aminopyridines containing fused ring substituents |
| 08/31/2000 | WO2000050047A2 Composition for the treatment of psoriasis |
| 08/31/2000 | WO2000050032A1 Antitumour synergistic composition |
| 08/31/2000 | DE19908537A1 Verwendung von polycyclischen 2-Amino-Thiazol Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas Use of 2-amino-thiazole polycyclic systems for the production of medicaments for the prophylaxis or treatment of obesity |
| 08/31/2000 | CA2363036A1 Composition for the treatment of psoriasis |
| 08/31/2000 | CA2361826A1 Antitumour synergistic composition |
| 08/30/2000 | CN1265037A Soya extract, process for its prepn. and pharmaceutical compsn. |
| 08/29/2000 | US6110914 Spiroazabicyclic heterocyclic compounds |
| 08/24/2000 | WO2000048988A1 Phenylalaninol derivatives |
| 08/24/2000 | WO2000048592A1 Essential fatty acids in the prevention of cardiovascular events |
| 08/23/2000 | CN1263762A Cosmetic composite and method for reducing skin aging procedure |
| 08/16/2000 | EP1027064A1 Method for removing undesirable toxic alkaloids from plants or vegetable preparations |
| 08/10/2000 | WO2000046221A1 Sulfamato hydroxamic acid metalloprotease inhibitor |
| 08/10/2000 | WO2000045828A1 Soya extract containing lipids, process for its production, and pharmaceutical and cosmetic composition |
| 08/10/2000 | WO2000045819A1 Use of cholesterol-lowering agent |
| 08/10/2000 | WO2000045818A1 Use of 3-hydroxy-3-methylglutaryl coenzym a reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy |
| 08/10/2000 | WO2000045817A1 Drug combinations comprising (e) -7 - [4 -(4 -fluorophenyl) -6 - isopropyl -2 - [methyl (methylsulfonyl) amino] pyrimidin -5 -yl] (3r,5s) -3,5 - dihydroxyhept -6 - enoic acid and an inhibitor, inducer or substrate of p450 isoenzyme 3a4 |
| 08/10/2000 | DE19904352C1 Lipide enthaltender Soja-Extrakt, Verfahren zu dessen Herstellung und pharmazeutische bzw. kosmetische Zusammensetzung sowie deren Verwendung zur Prävention oder Behandlung von trockener Haut Lipids containing soy extract, process for its preparation and to pharmaceutical or cosmetic composition and the use thereof for the prevention or treatment of dry skin |
| 08/10/2000 | CA2362230A1 Sulfamato hydroxamic acid metalloprotease inhibitor |
| 08/10/2000 | CA2358641A1 Use of cholesterol-lowering agent |
| 08/10/2000 | CA2349703A1 Soya extract containing lipids, process for its production, and pharmaceutical and cosmetic composition |
| 08/09/2000 | EP1025838A1 A cosmetic composition and a method for reducing the ageing processes of skin |
| 08/03/2000 | WO2000044763A2 Compositions for treating inflammatory response |
| 08/03/2000 | WO2000044716A1 Acetylenic sulfonamide thiol tace inhibitors |
| 08/03/2000 | WO2000037062A3 Phospholipid complexes of proanthocyanidin a2 as antiatherosclerotic agents |
| 08/03/2000 | WO2000023065A3 Storable active substance concentrate with formoterol |
| 08/03/2000 | CA2361614E Compositions for treating inflammatory response |
| 08/03/2000 | CA2356480A1 Acetylenic sulfonamide thiol tace inhibitors |
| 08/03/2000 | CA2356313A1 Alkynyl containing hydroxamic acid derivatives, their preparation and their use as matrix metalloproteinase (mmp) inhibitors/tnf-alpha converting enzyme (tace) inhibitors |
| 08/02/2000 | CN1261800A Method of treatment of lever tumours and pharmaceutical compositions for use therein |
| 08/02/2000 | CN1261796A Self-emulsifying formulation for lipophilic compounds |
| 07/27/2000 | WO2000043378A1 New morpholinobenzamide salts |
| 07/27/2000 | CA2359105A1 New morpholinobenzamide salts |
| 07/20/2000 | WO2000042044A1 Novel aralkyl amines of spirofuropyridines useful in therapy |
| 07/20/2000 | WO2000042040A1 Tricyclic inhibitors of poly(adp-ribose) polymerases |
| 07/20/2000 | WO2000042031A2 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents |
| 07/20/2000 | WO2000041708A1 Composition for treating obesity and aesthetic treatment method |
| 07/20/2000 | WO2000041546A2 Novel exendin agonist formulations and methods of administration thereof |
| 07/20/2000 | CA2359990A1 Novel aralkyl amines of spirofuropyridines useful in therapy |
| 07/20/2000 | CA2359562A1 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents |
| 07/20/2000 | CA2356706A1 Novel exendin agonist formulations and methods of administration thereof |
| 07/20/2000 | CA2323711A1 Composition for treating obesity and aesthetic treatment method |
| 07/06/2000 | WO2000039131A1 Nitrogen containing heterobicycles as factor xa inhibitors |
| 07/06/2000 | WO2000038727A1 Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indications |
| 07/06/2000 | WO2000038725A1 Combinations for cardiovascular indications |
| 07/06/2000 | WO2000038701A1 Use of unsaponifiable matters of vegetable oils for preparing a medicine |
| 07/06/2000 | CA2356607A1 Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indications |
| 07/06/2000 | CA2356515A1 Combinations for cardiovascular indications |
| 07/06/2000 | CA2356098A1 Use of unsaponifiable matters of vegetable oils for preparing a medicine |
| 06/29/2000 | WO2000037141A1 Combination chemotherapy |
| 06/29/2000 | WO2000037064A2 Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma |
| 06/29/2000 | WO2000037062A2 Phospholipid complexes of proanthocyanidin a2 as antiatherosclerotic agents |
| 06/29/2000 | CA2352326A1 Combination chemotherapy |
| 06/28/2000 | CN1258295A Novel form of S-omeprazole |
| 06/15/2000 | WO2000034283A1 Novel triazolo(4,5-d)pyrimidine compounds |
| 06/15/2000 | WO2000034263A1 Benzofuran derivatives, their preparation and use |
| 06/15/2000 | CA2353618A1 Benzofuran derivatives, their preparation and use |
| 06/15/2000 | CA2351390A1 Thiourea inhibitors of herpes viruses |
| 06/13/2000 | US6074648 Galenic preparation for prevention and treatment of hepatocarcinoma |
| 06/08/2000 | WO2000032589A1 Eletriptan hydrobromide monohydrate |
| 06/08/2000 | WO2000032579A1 Substituted benzimidazoles and their use as parp inhibitors |
| 06/07/2000 | EP1005332A2 Pharmaceutical composition for reducing production of mcp-1 protein |
| 05/31/2000 | EP1003537A1 Et |
| 05/31/2000 | EP1003523A1 Method of treatment of liver tumours and pharmaceutical compositions for use therein |
| 05/31/2000 | EP1003486A2 Pharmaceutical compositions containing an effervescent acid-base couple |
| 05/25/2000 | WO2000029384A1 2-phenylbenzimidazoles and 2-phenylindoles, and production and use thereof |
| 05/24/2000 | EP1001797A1 Soya extract, process for its preparation and pharmaceutical composition |
| 05/18/2000 | WO2000027820A1 N-aryl(thio)anthranilic acid amide derivatives, their preparation and their use as vegf receptor tyrosine kinase inhibitors |
| 05/18/2000 | WO2000027364A1 New controlled release bead, a method of producing the same and multiple unit formulation comprising it |
| 05/18/2000 | DE19945814A1 Verfahren zur Zubereitung eines pharmazeutischen Artemisia-Extraktes und Vorrichtung zur elektrischen Moxibustion unter Verwendung des Extraktes A process for the preparation of a pharmaceutical Artemisia extract and moxibustion device for electrically using the extract |
| 05/18/2000 | CA2346898A1 N-aryl(thio)anthranilic acid amide derivatives, their preparation and their use as vegf receptor tyrosine kinase inhibitors |
| 05/11/2000 | WO2000025746A2 A process for the preparation of suspensions of drug particles for inhalation delivery |
| 05/10/2000 | CN1252723A Use of 7 alpha-methyl-17 alpha-ethyle-estrane derivative for treatment of atherosclerosis |
| 05/04/2000 | WO2000024743A1 Pyrano, piperidino, and thiopyrano compounds and methods of use |
| 05/04/2000 | CA2348576A1 Pyrano, piperidino, and thiopyrano compounds and methods of use |
| 05/03/2000 | EP0996622A1 Novel spiroazabicyclic heterocyclic compounds |
| 04/27/2000 | WO2000023065A2 Storable active substance concentrate with formoterol |
| 04/26/2000 | EP0994713A1 USE OF A 7$g(a)-METHYL-17$g(a)-ETHYNYL-ESTRANE DERIVATIVE FOR THE TREATMENT OF ATHEROSCLEROSIS |
| 04/26/2000 | CN1251309A Method for preparing medicinal absinthium extracted liquor and electro-moxibustion apparatus using said extracted liquor |
| 04/20/2000 | DE19847969A1 Stable liquid formulation of formoterol in solution or suspension medium, used after dilution for treatment of asthma by inhalation |
| 04/18/2000 | US6051564 Phosphatidic acid-comprising compositions |
| 04/11/2000 | US6048549 Powder compositions |
| 04/05/2000 | EP0989851A1 Self-emulsifying formulation for acidic lipophilic compounds |
| 03/30/2000 | WO2000016789A1 Method for removing undesirable toxic alkaloids from plants or vegetable preparations |
| 03/30/2000 | DE19849107A1 Verfahren zur Entfernung von unerwünschten, toxischen Alkaloiden aus Pflanzen oder aus pflanzlichen Zubereitungen A process for the removal of undesired toxic alkaloids from plants or from plant preparations |
| 03/28/2000 | CA2014472C N-acyl derivatives of the ll-e33288 antitumor antibiotics |
| 03/26/2000 | CA2403011A1 Apparatus for electrical moxibustion using the extract |
| 03/26/2000 | CA2283350A1 Method of preparing pharmaceutical artemisia extract and apparatus for electrical moxibustion using the extract |
| 03/16/2000 | WO2000013671A1 Immediate release tablet |
| 03/15/2000 | EP0984957A1 NOVEL FORM OF $i(S)OMEPRAZOLE |
| 03/09/2000 | WO2000012484A1 Tan-1057 derivatives |
| 03/09/2000 | DE19838998A1 Neue Naturstoffderivate New natural product derivatives |
| 02/24/2000 | WO2000009149A1 Tnf-derived peptides for use in treating oedema |
| 02/03/2000 | WO2000004890A1 Use of glucose uptake enhancer for reducing apoptosis |
| 02/03/2000 | CA2338211A1 Use of glucose uptake enhancer for reducing apoptosis |
| 12/23/1999 | WO1998054171A8 Novel form of s-omeprazole |
| 11/17/1999 | CN1235551A Pharmaceutical composition for diabetes |
| 10/19/1999 | US5968520 Plant extracts from alder and mountain ash; hangover remedy |
| 09/15/1999 | EP0941103A1 Pharmaceutical composition for treatment of diabetes |